CTRI/2012/02/002407已完成4 期
International Diabetes Management Practices Study - IDMPS
Sanofi Synthelabo I Ltd0 个研究点目标入组 12,519 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 12,519
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. All male and female adult patients (who have attained majority) diagnosed with type 1 and type 2 DM ,visiting physician during the recruitment period of the cross-sectional study, up to the number of patients allocated to the physician.
- •2. Written Informed Consent
排除标准
- •1. Concomitant participation to a clinical trial
- •2. Previous participation in this study
- •3. Current temporary insulin therapy (gestational diabetes, surgery, pancreas cancer)
研究者
相似试验
已完成
不适用
Study of different methods of disease management done for Diabetic Patients with various methods of evaluation of Diabetes and Treatment patterns adapted by doctors.CTRI/2018/04/013100Sanofi India Limited8,426
进行中（未招募）
不适用
Study of Diabetes treatment management across region by different investigator for both type 1 & type 2 diabetes patientsCTRI/2019/03/017914Sanofi India Limited
已完成
不适用
Diabetes care Implementation StudyDiabetes Mellitus type two (DM2)Nutritional, Metabolic, EndocrineDiabetesISRCTN21523044niversity Medical Centre Utrecht (UMCU) (The Netherlands)3,500
招募中
不适用
Multicenter Investigation for Diabetes mellitus in AtheroSclerosisPatients admitted to the participating institution for 1. Acute myocardial infarction within 24 hours after symptom onset 2. Angina pectoris requiring PCI 3. Heart failure 4. Atrial fibrillation undergoing catheter ablation 5. Cerebral infarction 6. Transient ischemic attackJPRN-UMIN000010039ational Cerebral and Cardiovascular Center5,000
已完成
不适用
Diabetes UK StudyTopic: Diabetes Research NetworkSubtopic: Type 2Disease: Nephropathy, Cardiovascular disease, Hypertension, Dyslipidaemia, Diabetic Control, Multiple complicationsNutritional, Metabolic, EndocrineChronic kidney diseaseISRCTN85900874South Tees Hospitals NHS Foundation Trust (UK)600